Moreover, there was no evidence indicating the involvement of the interaction between HLA-DR2 and CTLA-4 in MS development among European Caucasians; conversely, the analysis of the Shanghai Chinese subjects indicated the presence of such an interaction [144]. This evidence concerns the gene CTLA4 and myeloid sarcoma.